Biotech: Page 39

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Oncology Performance Edge, Health Strategies Group’s recently launched strategic research service, helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources. “The oncology market is significantly different from others,...

    By PharmaVoice Team • Dec. 28, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Year Ahead

    Looking back to the varying changes and pressures the industry has endured, and ahead to how the industry will need to reinvent itself to continue to prosper, companies are adapting to longer-term marketplace trends and evolving patient needs. The industry is facing pressure from the economic, re...

    By Denise Myshko and Robin Robinson • Nov. 10, 2009
  • cancer healthcare Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Oncology

    As investments in cancer R&D stay high, waves of innovative new treatments are on the horizon.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Safety First Era

    The classwide requirement for Risk Evaluation and Mitigation Strategies (REMS) for opioid products is likely to have a profound impact on the pharmaceutical industry and healthcare. While most REMS involve only a medication guide — which is likely to have little impact on the prescribing process ...

    By PharmaVoice Team • Nov. 10, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    RNAI Technology

    Coming of Age: RNAi Technology As advances in genetics ­continue to improve our understanding of ­disease, RNAi will have the opportunity to create entirely new classes of medicines. Researchers say RNA-based therapeutic technology will have a tremendous impact on pharmaceutical research in the n...

    By Denise Myshko • Nov. 10, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Innovation Challenge

    There has been a great deal of discussion related to the challenges­ ­hampering innovation to create differentiated medicines. Never before have research and cutting-edge science been more important to ensure a steady flow of innovation. Much has been made of the industry’s decline in R&D pro...

    By PharmaVoice Team • Nov. 10, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Executive Suite

    Meeting challenges head-on David E. I. Pyott, CBE Chairman of the Board and CEO Allergan Inc. Allergan draws stability, strength, and value from its growth equation — a business model that balances diverse specialties with a focused approach and a leadership presence in markets around the globe. ...

    By PharmaVoice Team • Nov. 10, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Stanley BARSHAY Dr. Richard BOWLES Richard CLARK Willie DEESE Kenneth FRAZIER Dr. Peter KIM Raul KOHAN Merck Unveils Post-Merger Organizational Structure Merck has announced its new organizational structure following the completion of its merger with Schering-Plough. The new M...

    By PharmaVoice Team • Nov. 10, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    November 16-17 Pharmaceutical Coverage & Reimbursement Conference Washington, D.C. Q1 Productions, q1productions.com November 16-17 The 3rd Pediatric Clinical Trials Grand Hyatt Washington, Washington, D.C. ExL Pharma, exlpharma.com November 17-18, 2009 13th Advanced Forum on Structuring, Neg...

    By PharmaVoice Team • Nov. 9, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Index

    Julian Adams, Ph.D. President, Research and ­Development and Chief Scientific Officer, Infinity ­Pharmaceuticals Inc. Brent Ahrens. General Partner, Canaan Partners Kenneth C. Aldrich. CEO, Chairman, and Co-Founder, ­International Stem Cell Corp. Meryl Allison. Principal, Deloitte Consulting Karl...

    By PharmaVoice Team • Nov. 9, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    inVentiv Health’s recently launched risk evaluation and mitigation strategy (REMS) offering provides pharmaceutical and biotechnology clients with a customizable suite of REMS-related services that can be delivered through a single, integrated program. In an effort to assure safe use of prescript...

    By PharmaVoice Team • Nov. 9, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    In Memoriam Linda Ley Ciccarelli Linda Ciccarelli, VP and senior director of media services at Sudler & Hennessey, passed away on Sunday, Sept. 27, 2009, at her home in Wakefield, R.I. A founding member of the Association of Healthcare Media Directors (AHMD), Ms. Ciccarelli was a longtime lea...

    By PharmaVoice Team • Nov. 9, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    2010 — Time to Move Forward The consensus is pretty clear: 2009 is best left behind. People began writing off this year back in June and started setting their sights on first-quarter 2010. Fiscal projections aside, this Gregorian leapfrog of the calendar was more of a mindset throughout the indus...

    By Taren Grom • Nov. 9, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Felix Theeuwes — Durect Results

    Results With more than 30 years experience in developing innovative drugdelivery technologies, Dr.Felix Theeuwes as chairman and chief scientific officer of Durect, is directing the startup company with the goal of commercializing pharmaceutical systems that . BY KIM RIBBINK Photos: Scott Lewis C...

    By PharmaVoice Team • Nov. 4, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Biotech Clusters

    held in Toronto in June, drew exhibitors from 28 countries and 47 U.S. states many of whom were in attendance to unveil their region’s assets as biotechnology centers of excellence. The message being delivered was biotech “cluster.” State and city officials were eager to reach out to the 15,000 p...

    By Alex Robinson and Taren Grom • Nov. 4, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Animal Farm — The Promise of Xenotransplantation

    Animal Farm BY DENISE MYSHKO NO ONE WOULD DISPUTE THAT THERE IS A SHORTAGE OF HEARTS, KIDNEYS, OR LIVERS FOR THOSE WHO REQUIRE A NEW ONE. Last year in the United States alone, 6,000 people died while awaiting an organ transplant. Campaigns to increase organ donation have been somewhat successful ...

    By PharmaVoice Team • Nov. 4, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Andrew R.J. BONFIELD Bristol Myers Squibb Appoints New Senior VP and Chief Financial Officer Andrew R.J. Bonfield joins Bristol Myers Squibb as senior VP and chief financial officer. Mr. Bonfield, 39, served most recently as executive director of finance at BGGroup Plc., a multibillio...

    By PharmaVoice Team • Nov. 3, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES West Pharmaceutical Services Inc. has launched eWestDirect.com, the industry’s first ecommerce enabled Website focused on supporting cus tomers with online technical guidance,as well as a source for buying pharma ceutical closures....

    By PharmaVoice Team • Nov. 3, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    CROs: Mission Possible

    MISSION ANALYSTS … JOSEPH AVELLONE,M.D. President and CEO,Veritas Medicine Inc., Cambridge, Mass.;Veritas Medicine is a leading provider of Internet and patientdatabase services to identify and recruit patients into appropriate clinical trials ALFRED G.CHILDERS,PH.D. Principal and president of ad...

    By PharmaVoice Team • Nov. 2, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Debby Jo Blank — Point-Blank

    “IT’S NOT AS HARD AS IT SOUNDS,” Dr. Blank responds when asked how she juggles the myriad tasks assigned to her as chief business officer of healthcare and agriculture at Genencor International Inc. “Genencor has an objectivesetting process every year and we run the company by organizing our acti...

    By Kim Ribbink • Nov. 2, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Image is Everything

    Research into the human genome and intricate studies of disease states are opening the door to personalized therapy. But for those therapies to reach the right target audience, accurate and early diagnosis of disease are essential. Amersham Health, which develops and markets diagnostic pharmaceut...

    By PharmaVoice Team • Nov. 2, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharma POOL Robert GELBARD ICN Pharmaceuticals Appoints Former Ambassador to Head International Efforts Former Ambassador Robert Gelbard joins ICN Pharmaceuticals Inc. as senior VP for international affairs and government relations. Mr. Gelbard is the com pany representative with foreign governme...

    By PharmaVoice Team • Nov. 2, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES BioSpace Inc., a provider of Webbased products and information services to the life sciences industry, has formed a collaboration with MediBic, a Japanese bioventure company, to exchange information in an effort to support new biot...

    By PharmaVoice Team • Nov. 2, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Noonan Russo Communications has agreed to merge its operations with the public relations division of Euro RSCG Healthview, establishing a new company — Noonan Russo Presence Euro RSCG. The new entity, a differentiated communicatio...

    By PharmaVoice Team • Oct. 30, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Supplier Showcase

    AmerisourceBergen Specialty Group AmerisourceBergen Corp. 3101 Gaylord Pkwy. Frisco, TX 75034 Phone: 469-365-7000 www.absg.com AmerisourceBergen Specialty Group provides comprehensive resources to market, support and deliver specialty pharmaceutical products to providers and patients. Our ­Knowle...

    By PharmaVoice Team • Oct. 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh EDitorS Carolyn Gretton Denise Myshko Kim Ribbink design associate Ariel Medel national account manager Cathy Tracy CIRCULATION Kathy Deiuliis Copyright 2009 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Vol...

    By PharmaVoice Team • Oct. 27, 2009